Ransh Pharma Private Limited
About Ransh Pharma Private Limited
Data last updated:
Ransh Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 28 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74994AP2018PTC108036. Its GSTIN is 37AAICR8549J1ZN (Andhra Pradesh).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹10.94 Cr. It is led by directors including Chitakana China Penta Rao (Managing Director) and Karri Poorna Chandra Rao.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 4N De – Notified Area – Apsez Atchutapuram Rambilli Mandal, Visakhapatnam, Andhra Pradesh, India – 531061.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.75 Cr, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹25.31 Lakh (net margin 1.2%) and EBITDA of ₹3.81 Cr (EBITDA margin 17.5%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years.
As per MCA filings, the company has open charges of ₹19.75 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 4N De – Notified Area – Apsez Atchutapuram Rambilli Mandal, Visakhapatnam, Andhra Pradesh, India – 531061
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ransh Pharma Private Limited
The main business activity of Ransh Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ransh Pharma Private Limited FY 2025 filings available
Ransh Pharma Private Limited reported revenue of ₹21.75 Cr (up 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ransh Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 77% over three years, including 27% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ransh Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.81 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25.31 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ransh Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ransh Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ransh Pharma Private Limited
Ransh Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gangwal Chemicals Pvt Ltd | ₹23.32 Cr (FY 2024) | •••• | •••• | 2264302.0% | •••• | Mumbai, Maharashtra, India |
| Yegna Manojavam Drugs & Chemicals Limited | ₹23.07 Cr (FY 2018) | •••• | •••• | 32.0% | •••• | Hyderabad, Telangana, India |
| Kekule Life Sciences Limited | ₹22.9 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Hyderabad, Telangana, India |
| Innorex Pharmaceuticals Private Limited | ₹22.73 Cr (FY 2025) | •••• | •••• | 90.0% | •••• | Mumbai, Maharashtra, India |
| Shakti Lifescience Private Limited | ₹21.77 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Ransh Pharma Private Limited this company | ₹21.75 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Ramis Laboratories Private Limited | ₹21.59 Cr (FY 2024) | •••• | •••• | 192.0% | •••• | Quthubullapur Hyderabad, Telangana, India |
| Alchymars Icm SM Private Limited | ₹21.14 Cr (FY 2021) | •••• | •••• | 44.0% | •••• | Alathur, Tamil Nadu, India |
| Avance Healthcare Private Limited | ₹21.12 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Rajkot, Gujarat, India |
| Vav Life Sciences Private Limited | ₹20.87 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Norrish Laboratories Private Limited | ₹20.76 Cr (FY 2024) | •••• | •••• | 168.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Ransh Pharma by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ransh Pharma Private Limited
Ransh Pharma Private Limited is audited by M S P R & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M S P R & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ransh Pharma Private Limited
Ransh Pharma has 12 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karri Poorna Chandra Rao | Director | 13 Jun 2018 | 8 Years 3 Months | Current |
| Narasingarao Karri | Director | 13 Jun 2018 | 8 Years 3 Months | Current |
| Rama Mohan Rao Dodda | Director | 05 Mar 2025 | 1 Years 7 Months | Current |
| Gowri Karri Sankara Rao | Director | 28 Mar 2018 | 8 Years 6 Months | Current |
| Vijaya Kumar Villuri | Director | 19 Feb 2022 | 4 Years 7 Months | Current |
| Chitakana China Penta Rao | Managing Director | 19 Feb 2022 | 4 Years 7 Months | Current |
Ownership and Shareholding of Ransh Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ransh Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2023 | Sidbi | ₹3.9 Cr | Open |
| 29 Apr 2023 | Others | ₹17.65 Lakh | Open |
| 07 Feb 2022 | Sidbi | ₹2.18 Cr | Open |
| 29 Nov 2021 | Sidbi | ₹3 Cr | Open |
| 31 Jul 2020 | Sidbi | ₹50 Lakh | Open |
Total charge records: 6 View all charges
Legal Cases of Ransh Pharma Private Limited
Ransh Pharma Private Limited has 3 court cases on record: 1 filed by Ransh Pharma, 2 filed against it. 1 case is pending and 2 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Visakapatnam, Andhra Pradesh | Court case (COS) | Filed against the company by Metta Pharmaceuticals Pvt. Ltd | Pending |
| District court, Visakapatnam, Andhra Pradesh | Civil suit | Filed against the company by Ams Steel Industries | Disposed |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Andhra Pradesh | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Ransh Pharma Private Limited
Ransh Pharma Private Limited has a workforce of 0 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ransh Pharma Private Limited
Ransh Pharma Private Limited has 23 board changes on record since 2018: 12 appointments and 11 cessations. The latest: Rama Mohan Rao Dodda was appointed as Director on 05 Mar 2025.
21 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ransh Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ransh Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ransh Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ransh Pharma Private Limited
Ransh Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAICR8549J1ZN | Andhra Pradesh | Active | 08 May 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ransh Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ransh Pharma Private Limited
Ransh Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 28 March 2018 (8+ years old) and is registered under CIN U74994AP2018PTC108036.
Ransh Pharma reported revenue of ₹21.75 Cr for FY 2025 (up 27% YoY).
Ransh Pharma has 12 current directors:
- Chitakana China Penta Rao - Managing Director
- Karri Poorna Chandra Rao - Director
- Narasingarao Karri - Director
- Rama Mohan Rao Dodda - Director
- Gowri Karri Sankara Rao - Director
- Vijaya Kumar Villuri - Director
- Naidu Kandregula - Director
- Venkata Kanakadurga Putta - Director
- Sreedevi Veligatla - Director
- Tatini Radhakrishna - Director
- Vasudha Veligatla - Director
- Venkataramana Veligatla - Director
Ransh Pharma reported a net profit of ₹25.31 Lakh (net margin 1.2%) and EBITDA of ₹3.81 Cr (EBITDA margin 17.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ransh Pharma is 77% over three years. In the latest year (FY 2025) revenue rose 27%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ransh Pharma is 37AAICR8549J1ZN, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Ransh Pharma is U74994AP2018PTC108036. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ransh Pharma has 3 court cases on record: 1 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.
Ransh Pharma was incorporated on 28 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Ransh Pharma by revenue are Gangwal Chemicals Pvt Ltd, Yegna Manojavam Drugs & Chemicals Limited, Kekule Life Sciences Limited, Innorex Pharmaceuticals Private Limited, Shakti Lifescience Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Rama Mohan Rao Dodda was appointed as Director on 05 Mar 2025. Sreedevi Veligatla was appointed as Director on 28 Sep 2024. Tatini Radhakrishna was appointed as Director on 28 Sep 2024. Ransh Pharma has 23 board changes on record in total.